Prophylactic use of alendronate in elderly patients requiring oral prednisolone for whatever condition dramatically reduces the risk of hip fracture, at least in the short term, a new retrospective ...

Please provide your email address to receive an email when new articles are posted on . Adults with overweight or obesity, but not type 2 diabetes, lost 14.9% of their body weight after 46 weeks of ...

Heckbert SR, Li G, Cummings SR, Smith NL, Psaty BM. Use of alendronate and risk of incident atrial fibrillation in women. Arch Intern Med 2008;168:826-831. Data from the Group Health Atrial ...

Romosozumab plus alendronate vs alendronate alone was associated with improved lumbar spine BMD among postmenopausal women with T2D and osteoporosis. Romosozumab followed by alendronate treatment ...

In postmenopausal women with osteoporosis, prior fracture, and type 2 diabetes, 12 months of romosozumab significantly improved bone strength when combined with alendronate, compared with alendronate ...

Compared with alendronate, teriparatide was associated with significantly greater pain reduction and better quality of life among postmenopausal women with osteoporosis. Teriparatide has a favorable ...

Please provide your email address to receive an email when new articles are posted on . Adults treated with prednisolone and alendronate had reduced risk for hip fracture, major osteoporotic fracture, ...

Statin pills for patient with high cholesterol Decrease in bone mass is common in the first 6 to 12 months after kidney transplantation. Long-term use of alendronate, a bisphosphonate, may slow bone ...

Alendronate and teriparatide both improve BMD in osteoporotic patients, and it seems logical that combination therapy with both agents would have a higher efficacy than either of them alone. When this ...

Alendronate is frequently used to treat postmenopausal osteoporosis; however, the effects of long-term treatment on BMD, bone turnover, and fracture risk remain poorly characterized. The Fracture ...

(HealthDay)—For females with osteoporosis, the rate of adjacent-level vertebral fractures is relatively low, with reduced odds with bisphosphonate therapy, according to a study published in the Dec. 1 ...

Bisphosphonate therapy is the current standard of care for the prevention and treatment of glucocorticoid-induced osteoporosis. Studies of anabolic therapy in patients who are receiving long-term ...